Department of Medicine, Center for Behavioral Cardiovascular Health, Columbia University Medical Center, 622 West 168th Street, PH9-311, New York, NY, 10032, USA.
Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
J Behav Med. 2018 Apr;41(2):261-268. doi: 10.1007/s10865-017-9906-3. Epub 2017 Dec 4.
Posttraumatic stress disorder (PTSD) after acute medical events is associated with medication nonadherence. The mechanisms of PTSD-related nonadherence are poorly understood. We tested whether patients with elevated PTSD symptoms induced by suspected acute coronary syndrome (ACS) were more likely to have aversive cognitions towards cardiovascular medications. We enrolled a consecutive cohort of patients who presented to the emergency department with suspected ACS. One month after discharge, ACS-induced PTSD symptoms were assessed using the PTSD Checklist (PCL-S), and patients were asked "how often did" (1) "you miss your heart medication because you did not want to be reminded about your heart problem"; (2) "thinking about your heart medication make you feel nervous or anxious"; and (3) "thinking about your heart medication make you think about your risk for future heart problems." Logistic regression was used to determine the association between elevated PTSD symptoms and each aversive cognition, adjusting for age, sex, race, ethnicity, education, depression, and ACS status. Of 424 patients included, 15.8% had elevated PTSD symptoms (PCL-S ≥ 34). In adjusted analyses, higher PCL-S scores were associated with missing medications to avoid reminders of heart disease (OR 1.22 per 5-point PCL-S increase, 95%CI 1.07-1.40), as well as anxiety (OR 1.34, 95%CI 1.19-1.51) and thoughts of future risk (OR 1.19, 95%CI 1.08-1.32) when thinking about cardiovascular medications. We concluded that patients with elevated PTSD symptoms following suspected ACS were more likely to report aversive cognitions about their cardiovascular medications, suggesting that medications can act as traumatic reminders of the cardiac event and ongoing risk in this group.
创伤后应激障碍(PTSD)是急性医疗事件后的一种病症,与药物治疗不依从有关。但 PTSD 相关不依从的机制尚不清楚。我们检验了怀疑患有急性冠状动脉综合征(ACS)的患者,其 PTSD 症状升高是否更容易对心血管药物产生厌恶认知。
我们纳入了一组连续就诊于急诊科的疑似 ACS 患者。在出院后 1 个月,使用 PTSD 检查表(PCL-S)评估 ACS 引起的 PTSD 症状,询问患者:(1)“你因为不想想起心脏问题而错过心脏药物的情况有多少次?”;(2)“一想到你的心脏药物就会感到紧张或焦虑”;以及(3)“一想到你的心脏药物就会想到你未来患心脏病的风险”。使用逻辑回归确定 PTSD 症状升高与每种厌恶认知之间的关联,调整因素包括年龄、性别、种族、民族、教育程度、抑郁和 ACS 状况。在纳入的 424 例患者中,有 15.8%的患者 PTSD 症状升高(PCL-S≥34)。在调整分析中,PCL-S 评分越高,与漏服药物以避免想起心脏病有关(PCL-S 每增加 5 分,OR 为 1.22,95%CI 为 1.07-1.40),与焦虑(OR 为 1.34,95%CI 为 1.19-1.51)和思考未来风险(OR 为 1.19,95%CI 为 1.08-1.32)有关。
我们的结论是,怀疑患有 ACS 后的 PTSD 症状升高的患者更有可能报告对心血管药物的厌恶认知,这表明药物可能会成为该组患者对心脏事件和持续风险的创伤性提醒。